May 31, 2017 / 11:14 AM / 4 months ago

BRIEF-Kalytera Therapeutics Q1 loss per share $0.02

May 31 (Reuters) - Kalytera Therapeutics Inc

* Kalytera reports first quarter 2017 financial results

* Kalytera Therapeutics Inc qtrly loss per share $0.02

* Working capital totaled $1.8 million, including cash and cash equivalents of $3.1 million, as of March 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below